Vicapsys Life Sciences
$1.46
0
+$0.47+47.47% Monday 13:34
Statistics
Day High
0.51
Day Low
0.51
52W High
1.77
52W Low
0.15
Volume
100
Avg. Volume
20
Mkt Cap
47.26M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
30SepExpected
Expected EPS
N/A
Actual EPS
-0.0064
Financials
-Profit Margin
Unprofitable0Revenue
-1.98MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow VICP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Its product is applied to transplantation therapies and related stem-cell applications in the transplantation field. The company is also developing VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.
Show more...
CEO
Mr. Federico Pier
Employees
2
Country
US
ISIN
US92560A1060
Listings
0 Comments
Share your thoughts
FAQ
What is Vicapsys Life Sciences stock price today?▼
The current price of VICP is $1.46 USD — it has increased by +47.47% in the past 24 hours. Watch Vicapsys Life Sciences stock price performance more closely on the chart.
What is Vicapsys Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vicapsys Life Sciences stocks are traded under the ticker VICP.
What is Vicapsys Life Sciences market cap?▼
Today Vicapsys Life Sciences has the market capitalization of 47.26M
What were Vicapsys Life Sciences earnings last quarter?▼
VICP earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vicapsys Life Sciences revenue for the last year?▼
Vicapsys Life Sciences revenue for the last year amounts to 0 USD.
What is Vicapsys Life Sciences net income for the last year?▼
VICP net income for the last year is -1.98M USD.
How many employees does Vicapsys Life Sciences have?▼
As of April 02, 2026, the company has 2 employees.
In which sector is Vicapsys Life Sciences located?▼
Vicapsys Life Sciences operates in the Health Care sector.
When did Vicapsys Life Sciences complete a stock split?▼
The last stock split for Vicapsys Life Sciences was on November 02, 2017 with a ratio of 1:100.
Where is Vicapsys Life Sciences headquartered?▼
Vicapsys Life Sciences is headquartered in Suwanee, US.